-
We create value
-
We invest in people
-
You have an idea? Contact us
-
R&D Infrastructure for medical technologies
-
Creating a positive
social impact
About Us
NGT HealthCare II (“NGT”) is an early-stage medical device and life sciences venture capital fund, investing in promising technologies.
NGT enjoys a very significant risk reduction mechanism , by means of high non-dilutive leverage via Israel’s Innovation Authority (“IIA”).
Close relationships with many of Israel’s leading universities, hospitals and research institutions provide NGT with a rich flow of investment opportunities.
Wide network with multinational corporations enables NGT to create value to its portfolio companies.
NGT is structured as an impact fund, located in Nazareth, aligned with 3 UN SDGs.
At NGT we are always aiming beyond our horizon, expanding our network, please be in touch.
Geshem: Emergency Relief Fund for Israel's Startups
Under Establishment
Amidst adversity, opportunity unfolds. The ongoing conflict has cast a challenging shadow over Israel’s dynamic startup landscape, particularly impacting the promising seed-stage enterprises. These ventures, the bedrock of our economic future, face unprecedented vulnerability, grappling with funding hurdles and unpredictable delays during these tumultuous times.
Our Partners
Discover the esteemed partners who fuel our mission to revolutionize the biomedical and health industries through strategic investments and collaborative support.
Multi-disciplined Management Team
Zohar Gendler
Managing Partner & CEO
Zohar Gendler
Led the establishment and investment in more than 50 companies, such as Prolor Biotech (sold to OPKO, $480M), Mazor Robotics (sold to Medtronic, $1.6B), ReWalk (NASDAQ: RWLK), Corindus (sold to Siemens, $1.1B), and many others.
Livnat Ben-Zur
Chief Business & Technology Officer
Livnat Ben-Zur
Ms. Ben-Zur brings over 20 years of experience in the medical device and healthcare industries, holding executive positions in management, business and marketing, in the United States and in Israel.
Livnat has an extensive knowhow in spearheading global product development projects, and leading global business development efforts in various sectors as well as leading development of complex product portfolios from design & development through clinical and production phases up to commercial launch.
Prior to joining NGT, Livnat was the CEO of Corolabs, a deep-lung inhaled therapies, and prior to that the General Manager of Regentis Biomaterials, a tissue regeneration company.
Livnat served as VP Business Development & Director of Women’s Health Program at Galil Medical, where she spearheaded product development processes related to the breast and gynecology applications, as well as managed the clinical program of these applications. Before that Ms. Ben-Zur served as a Director of Marketing of Medinol Ltd, and as Business director of Medical Technology group of Datamonitor Inc.
She holds MBA in marketing and International Business from Tel Aviv University and Bachelor of Sciences, in Biology from Tel Aviv University.
Nizar Mishael
Managing Partner & CFO
Nizar Mishael
Co-founder of NGT Fund I. Over 15 years experience as CFO of start-up companies: hands-on financial experience from seed investment to early and late financing rounds, with deep understanding of structuring complex investment and business interactions, in addition to financial and accounting expertise.
Tamar Kedar Harris
Director of Investor Relations
Tamar Kedar Harris
Over 15 years of managerial experience in the start-up arena, in various positions including: operations, business development and investor relations. Brings deep and extensive understanding of the social intricacies of the Israeli society.
Haya Fahoum Darawshi
Administrative Manager & Assistant to CFO
Haya Fahoum Darawshi
Joined NGT3 in 2015, holds BA in Economics and Management from the Max Stern Yezreel Valley College.
Lina Totry Ghrayeb
Accounting assistant
Lina Totry Ghrayeb
Began her career at NGT3 in 2003.
Responsible for the bookkeeping , salaries and portfolio etc. for the managing company.
Lina hold BA in Statistics and Special Education from the Haifa University.
Social Impact
Good Health and Wellbeing
By accommodating unmet medical needs, quality of life improves, lives are saved, patient welfare is improved, and medical costs are reduced. NGT portfolio companies are all in the medical fields, aligned with SDG #3.
Equity, Diversity & Inclusion
Geographically Underserved
Cultivating an entrepreneurial ecosystem in the Northern periphery of Israel, and catalyzing economic growth is a national mission. Working in Nazareth gives employment opportunities for talented people from the region, jumpstarting their careers. With salaries higher than the national average, social mobility can be achieved.
Impact on Arab Society
Integrate more Arab workers
Contact us
Address
Wadi el-Haj St 13 , Nazareth, Israel
Phone
+972-4-6098600
info@ngt-healthcare2.com